broad-spectrum antibacterial activity against aerobic and anaerobic bacteria and MRSA Nadifloxacin does not show cross-resistance with other new quinolones.
Cream
مرتان يوميا
35 EGP
broad-spectrum antibacterial activity against aerobic and anaerobic bacteria and MRSA Nadifloxacin does not show cross-resistance with other new quinolones.
Note: All the provided information about this drug does not substitute for consulting a doctor.